Multidrug-resistant tuberculosis (MDR-TB)

EducAir Online Educational Series

28th September 2023

Tuberculosis Surpasses COVID-19 as Most Deadly Infectious Disease

17th November 2023

EducAir Online Educational Series

28th September 2023

Tuberculosis Surpasses COVID-19 as Most Deadly Infectious Disease

17th November 2023
0

Multidrug-resistant tuberculosis (MDR-TB)

Press Releases 2023

Multidrug-resistant tuberculosis (MDR-TB): Clinical trial starts in South Africa

 

Click on the image to read the full article.

Related posts

TITLE: Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial

Read more

The Order of Mapungubwe Honour Awarded to Prof K Dheda

Read more

Understanding food allergies: symptoms, common triggers and how to manage them

Read more